Dual κ‐agonist/μ‐antagonist opioid receptor modulation reduces levodopa‐induced dyskinesia and corrects dysregulated striatal changes in the nonhuman primate model of Parkinson disease

Publisher： John Wiley & Sons Inc

E-ISSN： 1531-8249|77|6|930-941

ISSN： 0364-5134

Source： ANNALS OF NEUROLOGY, Vol.77, Iss.6, 2015-06, pp. : 930-941

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nicotine reduces established levodopa‐induced dyskinesias in a monkey model of Parkinson's disease

By  

MOVEMENT DISORDERS, Vol. 28, Iss. 10, 2013-09 ,pp. : 1398-1406

John Wiley & Sons Inc

Access to resources Recommend Favorite

Coffee consumption and risk of levodopa‐induced dyskinesia in Parkinson's disease: The FRAGAMP study

By  

MOVEMENT DISORDERS, Vol. 30, Iss. 13, 2015-11 ,pp. : 1854-1856

John Wiley & Sons Inc

Access to resources Recommend Favorite

Amantadine extended release for levodopa‐induced dyskinesia in Parkinson's disease (EASED Study)

By  

MOVEMENT DISORDERS, Vol. 30, Iss. 6, 2015-05 ,pp. : 788-795

John Wiley & Sons Inc

Access to resources Recommend Favorite

Optogenetic Inhibition of the Subthalamic Nucleus Reduces Levodopa-Induced Dyskinesias in a Rat Model of Parkinson's Disease

By  

Stereotactic and Functional Neurosurgery, Vol. 94, Iss. 1, 2016-03 ,pp. : 41-53

Karger

Access to resources Recommend Favorite

Direct Effect of Subthalamic Nucleus Stimulation on Levodopa-Induced Peak-Dose Dyskinesia in Patients with Parkinson’s Disease

By  

Stereotactic and Functional Neurosurgery, Vol. 84, Iss. 4, 2006-09 ,pp. : 176-179

Karger

Access to resources Recommend Favorite